Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Ciproterone acetate improves hair regrowth and acne in most female patients.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

The document concludes that early and personalized treatment for PCOS in adolescents is crucial to manage symptoms and prevent long-term health issues.

Rosuvastatin improves lipid levels, reduces inflammation, but worsens insulin sensitivity in men with early-onset hair loss.

Certain changes in the SHBG gene may increase the risk of PCOS in Iraqi women.

The document concludes that new treatments for skin conditions are complex but effective, including spironolactone for female hair loss and propranolol for infantile hemangiomas.

Niosomes and ethosomes can effectively carry the drug spironolactone, potentially improving treatment for hair loss and reducing side effects.

The testes produce important hormones like testosterone and others that play key roles in male body functions.

Derinat may improve hair growth and quality of life in hair loss patients by reducing oxidative stress.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

PCOS is a common hormonal disorder in women linked to several health risks and can be managed through various treatments.

Spironolactone is used in dermatology to treat skin conditions related to hormones, but is not safe for pregnant women or men.

Androgens can both promote and prevent hair growth due to differences in gene expression in hair follicles.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Different types of androgens bind differently to two receptors, AR1 and AR2, in Atlantic croaker's brain and ovarian tissues, suggesting these receptors may control different androgen actions in fish.

Steroid sulfatase is important for activating hormones that affect memory, brain function, and certain diseases, and could be a target for treating hormone-related disorders.

Androgen receptors are active in many tissues of both male and female mice, not just reproductive organs.

The same hormone can affect gene expression differently in various tissues, which could lead to new treatments for conditions like hair loss.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Testosterone therapy can help improve sexual function, mood, and bone density in women with low androgen levels, but more research is needed on long-term safety.

Androgens block hair growth by disrupting cell signals; targeting GSK-3 may help treat hair loss.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Hidradenitis suppurativa improves with antiandrogen therapy.

Androgens increase muscle mass by promoting myoblast growth through ornithine decarboxylase.